Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review.

mesenteric ischemia pharmacovigilance septic shock (MeSH) systematic review vasopressors

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2022
Historique:
received: 30 11 2021
accepted: 21 04 2022
entrez: 9 6 2022
pubmed: 10 6 2022
medline: 10 6 2022
Statut: epublish

Résumé

Vasodilatory shock, such as septic shock, requires personalized management which include adequate fluid therapy and vasopressor treatments. While these potent drugs are numerous, they all aim to counterbalance the vasodilatory effects of a systemic inflammatory response syndrome. Their specific receptors include α- and β-adrenergic receptors, arginine-vasopressin receptors, angiotensin II receptors and dopamine receptors. Consequently, these may be associated with severe adverse effects, including acute mesenteric ischemia (AMI). As the risk of AMI depends on drug class, we aimed to review the evidence of plausible associations by performing a worldwide pharmacovigilance analysis based on the World Health Organization database, VigiBase®. Among 24 million reports, 104 AMI events were reported, and disproportionality analyses yielded significant association with all vasopressors, to the exception of selepressin. Furthermore, in a comprehensive literature review, we detailed mechanistic phenomena which may enhance vasopressor selection, in the course of treating vasodilatory shock.

Identifiants

pubmed: 35677822
doi: 10.3389/fmed.2022.826446
pmc: PMC9168038
doi:

Types de publication

Journal Article

Langues

eng

Pagination

826446

Informations de copyright

Copyright © 2022 Jozwiak, Geri, Laghlam, Boussion, Dolladille and Nguyen.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):367-76
pubmed: 6156335
Acta Anaesthesiol Scand. 2004 Feb;48(2):198-204
pubmed: 14995942
Clin Auton Res. 1993 Feb;3(1):5-13
pubmed: 8386574
Anesth Analg. 1993 Aug;77(2):227-31
pubmed: 8346819
Circulation. 1997 Mar 4;95(5):1122-5
pubmed: 9054839
J Am Coll Cardiol. 2018 Jul 10;72(2):173-182
pubmed: 29976291
N Engl J Med. 2014 Apr 24;370(17):1583-93
pubmed: 24635770
Shock. 2017 May;47(5):560-566
pubmed: 27879559
Curr Opin Crit Care. 2020 Aug;26(4):411-416
pubmed: 32487842
Eur Heart J. 2022 Feb 10;43(6):440-441
pubmed: 34922348
Medicine (Baltimore). 2018 Apr;97(16):e0431
pubmed: 29668606
Circulation. 1962 Jan;25:263-7
pubmed: 13885617
JAMA. 2020 Nov 10;324(18):1899-1901
pubmed: 32970139
Crit Care Med. 1998 Oct;26(10):1749-58
pubmed: 9781735
Shock. 2018 Jun;49(6):625-630
pubmed: 29040212
Am J Physiol Heart Circ Physiol. 2012 Nov 15;303(10):H1245-54
pubmed: 22961865
Intensive Care Med. 2018 Jul;44(7):1130-1132
pubmed: 28861671
Crit Care Med. 2006 May;34(5):1456-63
pubmed: 16557162
Curr Opin Crit Care. 2018 Aug;24(4):277-285
pubmed: 29877879
Crit Care Med. 1991 Aug;19(8):1084-6
pubmed: 1860334
Crit Care Med. 2002 Mar;30(3):497-500
pubmed: 11990905
Drug Saf. 2004;27(12):857-70
pubmed: 15366974
JAMA. 2019 Oct 15;322(15):1476-1485
pubmed: 31577035
Crit Care Med. 2016 Jan;44(1):23-31
pubmed: 26496451
Crit Care Med. 1999 May;27(5):893-900
pubmed: 10362410
Intensive Care Med. 2003 Feb;29(2):292-300
pubmed: 12594589
Crit Care Med. 2014 Aug;42(8):e550-9
pubmed: 24797374
Lancet. 2005 Mar 5-11;365(9462):871-5
pubmed: 15752531
Intensive Care Med. 2000 Jul;26(7):901-7
pubmed: 10990104
Arch Int Physiol Biochim. 1984 Nov;92(4):S11-20
pubmed: 6085236
Crit Care Med. 2017 Aug;45(8):1285-1294
pubmed: 28489648
Intensive Care Med. 2008 Dec;34(12):2226-34
pubmed: 18654759
Lancet. 1995 Dec 16;346(8990):1604
pubmed: 7500755
Circulation. 2019 Sep 24;140(13):1070-1080
pubmed: 31378084
J Am Coll Cardiol. 2019 Oct 1;74(13):1667-1678
pubmed: 31558250
Eur Heart J. 2021 Oct 7;42(38):3915-3928
pubmed: 34370839
Hypertension. 2001 Dec 1;38(6):1246-9
pubmed: 11751697
Semin Respir Crit Care Med. 2021 Feb;42(1):59-77
pubmed: 32820475
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1253-1261
pubmed: 32609011
N Engl J Med. 2016 Nov 03;375(18):1749-1755
pubmed: 27806233
Crit Care. 2019 Mar 14;23(1):91
pubmed: 30871607
Clin Sci. 1964 Oct;27:271-81
pubmed: 14220906
Crit Care Med. 2011 Apr;39(4):689-94
pubmed: 21263328
Crit Care. 2009;13(6):R190
pubmed: 19948019
Crit Care Med. 1996 Sep;24(9):1580-90
pubmed: 8797634
Br J Anaesth. 2018 Mar;120(3):517-524
pubmed: 29452808
Crit Care Med. 2000 Aug;28(8):2893-7
pubmed: 10966267
Crit Care Med. 2018 Jun;46(6):949-957
pubmed: 29509568
Crit Care Med. 2007 Jan;35(1):33-40
pubmed: 17133186
Am J Respir Crit Care Med. 2016 Sep 1;194(5):550-8
pubmed: 27398737
Crit Care. 2008;12(6):R143
pubmed: 19017409
Crit Care. 2017 Aug 15;21(1):213
pubmed: 28807037
Shock. 2010 Apr;33(4):375-80
pubmed: 19851126
Crit Care. 2014 Oct 06;18(5):534
pubmed: 25286986
Surg Gynecol Obstet. 1981 Dec;153(6):869-72
pubmed: 7029759
Intensive Care Med. 1997 Mar;23(3):282-7
pubmed: 9083230
Crit Care Med. 2003 Jun;31(6):1659-67
pubmed: 12794401
Circ Shock. 1985;17(4):273-84
pubmed: 4092342
Shock. 2008 Oct;30(4):417-21
pubmed: 18323749
Am J Respir Crit Care Med. 1999 Aug;160(2):458-65
pubmed: 10430714
J Intensive Care Med. 2013 Jul-Aug;28(4):237-40
pubmed: 22733722
Cells. 2021 Jul 13;10(7):
pubmed: 34359936
J Surg Res. 2019 Mar;235:410-423
pubmed: 30691823
Acta Anaesthesiol Scand. 2016 Nov;60(10):1347-1366
pubmed: 27576362
Stat Methods Med Res. 2013 Feb;22(1):57-69
pubmed: 21705438
Crit Care. 2010;14(4):R142
pubmed: 20670424
Ther Clin Risk Manag. 2015 Jul 14;11:1047-59
pubmed: 26203253
Drug Saf. 2016 Jun;39(6):469-90
pubmed: 26951233
Crit Care Med. 1997 Oct;25(10):1649-54
pubmed: 9377878
N Engl J Med. 2017 Aug 3;377(5):419-430
pubmed: 28528561
Eur J Clin Pharmacol. 1998 Jun;54(4):315-21
pubmed: 9696956
Front Pharmacol. 2019 Dec 23;10:1492
pubmed: 31920672
J Pharmacol Exp Ther. 2011 Jun;337(3):786-96
pubmed: 21411496
Lancet. 2007 Aug 25;370(9588):676-84
pubmed: 17720019
Intensive Care Med. 2018 Nov;44(11):1816-1825
pubmed: 29971593
Intensive Care Med. 2021 Nov;47(11):1181-1247
pubmed: 34599691
Best Pract Res Clin Anaesthesiol. 2008 Jun;22(2):335-50
pubmed: 18683479
Shock. 2017 Mar;47(3):296-302
pubmed: 28195969
Crit Care. 2019 Mar 27;23(1):98
pubmed: 30917843
Intensive Care Med. 2015 Apr;41(4):667-76
pubmed: 25731634
J Pharmacol Exp Ther. 2020 Nov;375(2):286-295
pubmed: 32943478
Anesthesiology. 1991 Jan;74(1):172-83
pubmed: 1986643
World J Emerg Surg. 2015 Sep 26;10:45
pubmed: 26413147
N Engl J Med. 2019 Jun 13;380(24):2377-2379
pubmed: 31189043
Pharmacol Rev. 2000 Sep;52(3):415-72
pubmed: 10977869
Acta Pharmacol Sin. 2002 Jul;23(7):654-8
pubmed: 12100762
N Engl J Med. 2010 Mar 4;362(9):779-89
pubmed: 20200382
Crit Care Med. 2010 Oct;38(10):1962-9
pubmed: 20639747
JAMA. 2017 Apr 11;317(14):1433-1442
pubmed: 28322415
Am J Respir Crit Care Med. 2002 Jul 1;166(1):98-104
pubmed: 12091178
Crit Care Med. 2014 Jul;42(7):e525-e533
pubmed: 24674922
Crit Care Med. 2011 Jan;39(1):119-25
pubmed: 20890184
Lancet. 2003 Nov 29;362(9398):1799-805
pubmed: 14654318
J Clin Monit Comput. 2018 Dec;32(6):967-968
pubmed: 29959580
Intensive Care Med. 2012 May;38(5):886-93
pubmed: 22302028
Intensive Care Med. 2006 Jun;32(6):875-80
pubmed: 16715327
N Engl J Med. 2008 Feb 28;358(9):877-87
pubmed: 18305265
Brain Pathol. 2010 May;20(3):613-22
pubmed: 20015289
Crit Care. 2021 Aug 21;25(1):302
pubmed: 34419120
Crit Care Med. 2012 Dec;40(12):3146-53
pubmed: 22926333
Intensive Care Med. 2019 Nov;45(11):1503-1517
pubmed: 31646370
J Clin Monit Comput. 2018 Dec;32(6):969-976
pubmed: 29569112
Intensive Care Med. 2010 Nov;36(11):1882-9
pubmed: 20689910
Ann Intensive Care. 2020 Jan 22;10(1):9
pubmed: 31970567
Eur J Anaesthesiol. 2016 Sep;33(9):638-44
pubmed: 27164015
Crit Care Med. 2011 Mar;39(3):450-5
pubmed: 21037469
JAMA. 1961 Dec 9;178:994-9
pubmed: 13884972
Microvasc Res. 2020 Nov;132:104068
pubmed: 32877698
J Neuroimmune Pharmacol. 2020 Mar;15(1):114-164
pubmed: 31077015
Shock. 2021 Aug 1;56(2):308-317
pubmed: 33443363
J Pharmacol Exp Ther. 2017 May;361(2):322-333
pubmed: 28223322
Crit Care Med. 2006 Mar;34(3):722-9
pubmed: 16505658
World J Gastroenterol. 2021 Jul 14;27(26):4088-4103
pubmed: 34326613
F1000Res. 2021 Jun 8;10:453
pubmed: 34621507
Ann Intensive Care. 2015 Dec;5(1):52
pubmed: 26152849
Circulation. 2020 Jul 21;142(3):303-305
pubmed: 32442023
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
Crit Care Med. 2003 Jun;31(6):1752-8
pubmed: 12794416
Lancet Oncol. 2018 Dec;19(12):1579-1589
pubmed: 30442497
Am J Physiol. 1982 Nov;243(5):H663-9
pubmed: 7137358
Front Pharmacol. 2020 May 06;11:563
pubmed: 32435192
Shock. 2008 Aug;30(2):166-72
pubmed: 18091574

Auteurs

Mathieu Jozwiak (M)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire l'Archet 1, Nice, France.
Equipe 2 CARRES UR2CA-Unité de Recherche Clinique Côte d'Azur, Université Côte d'Azur UCA, Nice, France.

Guillaume Geri (G)

Service de Médecine Intensive Réanimation, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France.

Driss Laghlam (D)

Service de Médecine Intensive Réanimation, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France.
Faculté de Médecine, Université de Paris, Paris, France.

Kevin Boussion (K)

Service de Médecine Intensive Réanimation, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France.

Charles Dolladille (C)

Department of Pharmacology, CHU de Caen, Caen, France.

Lee S Nguyen (LS)

Service de Médecine Intensive Réanimation, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France.

Classifications MeSH